ATC Group: R03AK06 Salmeterol and fluticasone

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of R03AK06 in the ATC hierarchy

Level Code Title
1 R Respiratory system
2 R03 Drugs for obstructive airway diseases
3 R03A Adrenergics, inhalants
4 R03AK Adrenergics and other drugs for obstructive airway diseases
5 R03AK06 Salmeterol and fluticasone

Related product monographs

Document Type Information Source  
 SALMEX Inhalation powder, pre-dispensed MPI, EU: SmPC Medicines Authority (MT)
 SEREFLO Pressurised inhalation, suspension MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 SERETIDE Inhaler MPI, EU: SmPC Medicines and Medical Devices Safety Authority (NZ)

United States medicines

Medicines classified under this ATC code globally

Albania (AL)

Australia (AU)

Austria (AT)

Brazil (BR)

Canada (CA)

Croatia (HR)

Cyprus (CY)

Ecuador (EC)

Estonia (EE)

Finland (FI)

France (FR)

Germany (DE)

Hong Kong (HK)

Ireland (IE)

Israel (IL)

Italy (IT)

Japan (JP)

Lithuania (LT)

Malta (MT)

Mexico (MX)

Netherlands (NL)

New Zealand (NZ)

Nigeria (NG)

Poland (PL)

Romania (RO)

Singapore (SG)

South Africa (ZA)

Spain (ES)

Tunisia (TN)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.